Loading...

Agile Therapeutics, Inc.

AGRX•NASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$1.51
$0.05(3.42%)

Agile Therapeutics, Inc. (AGRX) Stock Chart & Performance Analysis

Explore Agile Therapeutics, Inc.’s stock chart, historical data, and performance trends for a deeper market understanding.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
3.62%
3-Month Change
376.34%
6-Month Change
169.16%
Year-to-Date (YTD) Change
-17.93%
1-Year Change
-12.72%
3-Year Change
-99.93%
5-Year Change
-99.93%
All-Time (Max) Change
-99.99%

Analyzing Agile Therapeutics, Inc. (AGRX) Trends Across Multiple Time Frames

Agile Therapeutics, Inc. Charts reveal critical insights by breaking down performance into different periods from short-term swings to long-term trends. Agile Therapeutics, Inc. stock shows N/A 1-day change, indicating low volatility, while its 5-day change of N/A suggests a broader trend. Over a 1-month period, a 3.62% rise could signal a pushback, whereas a 3-month rise of 376.34% may reflect broader market sentiment. Longer timeframes help assess sustained performance. A 6-month change of 169.16% and a YTD drop of -17.93% might concern investors, but a 1-year loss of -12.72% and a 3-year drop of -99.93% could indicate resilience. The 5-year surge of -99.93% highlights weak historical growth, while the all-time return of -99.99% underscores long-term potential. Whether tracking intraday moves or multi-year trends, analyzing these metrics helps traders and investors make data-driven decisions.

Frequently Asked Questions

;